missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Phospho-MECP2 (Ser421) Polyclonal Antibody

Descrizione
This antibody is predicted to react with human and non-human primate based on 100% sequence homology. This antibody contains enough material to conduct 10 mini-Western blots.
MECP2 belongs to a family of nuclear proteins (including MBD1, MBD2, MBD3 and MBD4) that have a methyl-CpG binding domain. MECP2 is capable of binding specifically to methylated DNA. DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. MECP2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of mental retardation in females.
Specifica
Specifica
| Antigene | Phospho-MECP2 (Ser421) |
| Applicazioni | Western Blot |
| Classificazione | Polyclonal |
| Concentrazione | 0.25 mg/mL |
| Coniugato | Unconjugated |
| Formulazione | 0.01M HEPES with 0.1mg/mL BSA, 50% glycerol, 0.15M NaCl and no preservative; pH 7.5 |
| Gene | Mecp2 |
| N. accesso geni | Q00566, Q9Z2D6 |
| Alias gene | 1500041B07Rik; AUTSX3; D630021H01Rik; DKFZp686A24160; Mbd5; MECP2; MeCp-2 protein; methyl CpG binding protein 2; methyl-CpG binding protein 2; methyl-CpG-binding protein 2; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT; testis tissue sperm-binding protein Li 41a; WBP10 |
| Simboli geni | Mecp2 |
| Vedi altri risultati |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?